| 摘要 |
<p>The present invention is directed to a series of substituted pyridine compounds (I), a method for selectively controlling neurotransmitter release in mammals using these compounds, and pharmaceutical compositions containing these compounds. Preferred compounds are 3 (5 and or 6 substituted) pyridyl ethers. n = 1 4, R1 R6 as in the claims.</p> |
